188 related articles for article (PubMed ID: 30863490)
1. A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin.
Geagea AG; Rizzo M; Jurjus A; Cappello F; Leone A; Tomasello G; Gracia C; Al Kattar S; Massaad-Massade L; Eid A
Oncotarget; 2019 Feb; 10(13):1284-1305. PubMed ID: 30863490
[TBL] [Abstract][Full Text] [Related]
2. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
3. Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways.
Sun C; Yang X; Jin Z; Gao Z
J Chemother; 2023 May; 35(3):259-269. PubMed ID: 35731713
[TBL] [Abstract][Full Text] [Related]
4. Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal Cancer and Diabetes in Mice.
Kattar SA; Jurjus R; Pinon A; Leger DY; Jurjus A; Boukarim C; Diab-Assaf M; Liagre B
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664279
[TBL] [Abstract][Full Text] [Related]
5. Metformin Potentiates the Effects of Anlotinib in NSCLC
Zhu Z; Jiang T; Suo H; Xu S; Zhang C; Ying G; Yan Z
Front Pharmacol; 2021; 12():712181. PubMed ID: 34421608
[TBL] [Abstract][Full Text] [Related]
6. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer.
Mroueh FM; Noureldein M; Zeidan YH; Boutary S; Irani SAM; Eid S; Haddad M; Barakat R; Harb F; Costantine J; Kanj R; Sauleau EA; Ouhtit A; Azar ST; Eid AH; Eid AA
FASEB J; 2019 Dec; 33(12):14051-14066. PubMed ID: 31661292
[TBL] [Abstract][Full Text] [Related]
7. Metformin ameliorates experimental diabetic periodontitis independently of mammalian target of rapamycin (mTOR) inhibition by reducing NIMA-related kinase 7 (Nek7) expression.
Zhou X; Zhang P; Wang Q; Ji N; Xia S; Ding Y; Wang Q
J Periodontol; 2019 Sep; 90(9):1032-1042. PubMed ID: 30945296
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits the development and metastasis of colorectal cancer.
Sugiura K; Okabayashi K; Seishima R; Ishida T; Shigeta K; Tsuruta M; Hasegawa H; Kitagawa Y
Med Oncol; 2022 Jul; 39(9):136. PubMed ID: 35780231
[TBL] [Abstract][Full Text] [Related]
9. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
10. Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer.
Seo Y; Kim J; Park SJ; Park JJ; Cheon JH; Kim WH; Kim TI
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32911743
[TBL] [Abstract][Full Text] [Related]
11.
Wang D; Wu X
Oncol Lett; 2015 Aug; 10(2):975-981. PubMed ID: 26622608
[TBL] [Abstract][Full Text] [Related]
12. Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Thent ZC; Zaidun NH; Azmi MF; Senin MI; Haslan H; Salehuddin R
Curr Drug Targets; 2017; 18(6):734-750. PubMed ID: 27919208
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin Supplementation May Ameliorate Erectile Function in Rats With Streptozotocin-Induced Type 1 Diabetes by Inducing Autophagy and Inhibiting Apoptosis, Endothelial Dysfunction, and Corporal Fibrosis.
Lin H; Wang T; Ruan Y; Liu K; Li H; Wang S; Li M; Liu J
J Sex Med; 2018 Sep; 15(9):1246-1259. PubMed ID: 30224017
[TBL] [Abstract][Full Text] [Related]
14. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.
Hosono K; Endo H; Takahashi H; Sugiyama M; Uchiyama T; Suzuki K; Nozaki Y; Yoneda K; Fujita K; Yoneda M; Inamori M; Tomatsu A; Chihara T; Shimpo K; Nakagama H; Nakajima A
Mol Carcinog; 2010 Jul; 49(7):662-71. PubMed ID: 20564343
[TBL] [Abstract][Full Text] [Related]
15. Metformin Inhibits the Urea Cycle and Reduces Putrescine Generation in Colorectal Cancer Cell Lines.
Zhang T; Hu L; Tang JF; Xu H; Tian K; Wu MN; Huang SY; Du YM; Zhou P; Lu RJ; He S; Xu JM; Si JJ; Li J; Chen DL; Ran JH
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915902
[TBL] [Abstract][Full Text] [Related]
16. Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.
Li W; Hua B; Saud SM; Lin H; Hou W; Matter MS; Jia L; Colburn NH; Young MR
Mol Carcinog; 2015 Oct; 54(10):1096-109. PubMed ID: 24838344
[TBL] [Abstract][Full Text] [Related]
17. Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation.
Pérez-Revuelta BI; Hettich MM; Ciociaro A; Rotermund C; Kahle PJ; Krauss S; Di Monte DA
Cell Death Dis; 2014 May; 5(5):e1209. PubMed ID: 24810045
[TBL] [Abstract][Full Text] [Related]
18. Metformin attenuates diabetic renal injury via the AMPK-autophagy axis.
Sun T; Liu J; Xie C; Yang J; Zhao L; Yang J
Exp Ther Med; 2021 Jun; 21(6):578. PubMed ID: 33850550
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits skin tumor promotion in overweight and obese mice.
Checkley LA; Rho O; Angel JM; Cho J; Blando J; Beltran L; Hursting SD; DiGiovanni J
Cancer Prev Res (Phila); 2014 Jan; 7(1):54-64. PubMed ID: 24196830
[TBL] [Abstract][Full Text] [Related]
20. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.
Din FV; Valanciute A; Houde VP; Zibrova D; Green KA; Sakamoto K; Alessi DR; Dunlop MG
Gastroenterology; 2012 Jun; 142(7):1504-15.e3. PubMed ID: 22406476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
